183 related articles for article (PubMed ID: 3399759)
1. [Oral antidiabetic agents, yes but...].
Krzentowski G
Rev Med Brux; 1988 Apr; 9(3):144-7. PubMed ID: 3399759
[No Abstract] [Full Text] [Related]
2. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
Pernet A; Bäbler M; Ganz K
Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
[No Abstract] [Full Text] [Related]
3. [Oral antidiabetic agents: what are the choices?].
Crausaz FM
Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
[No Abstract] [Full Text] [Related]
4. [Oral antidiabetic agents including glucosidase inhibitors].
Raptis S
Internist (Berl); 1987 Apr; 28(4):243-53. PubMed ID: 3298124
[No Abstract] [Full Text] [Related]
5. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
6. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
[No Abstract] [Full Text] [Related]
7. Diabetes under control: Understanding oral antidiabetic agents.
Longo R
Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402
[No Abstract] [Full Text] [Related]
8. [Oral therapy of type II diabetes].
Haupt E; Schöffling K
Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363
[No Abstract] [Full Text] [Related]
9. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
10. Treating type 2 diabetes: targeting the many causative factors.
Sutherland JE; Hoehns JD
J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
[No Abstract] [Full Text] [Related]
11. Oral agent therapy in the treatment of type 2 diabetes.
Feinglos MN; Bethel MA
Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
[No Abstract] [Full Text] [Related]
12. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
13. [Long term efficacy and tolerance of antidiabetic treatments. New data].
Mirouze J
Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
[No Abstract] [Full Text] [Related]
14. [On the use of oral antidiabetic drugs].
Aarseth S
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1595-601. PubMed ID: 4588815
[No Abstract] [Full Text] [Related]
15. The oral hypoglycaemic agents reassess.
Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614
[No Abstract] [Full Text] [Related]
16. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
17. [Possibilities and limits of oral diabetes therapy].
Bruneder H
Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
[No Abstract] [Full Text] [Related]
18. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
19. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
[Next] [New Search]